AVITA MEDICAL DL-0001
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more
Market Cap & Net Worth: AVITA MEDICAL DL-0001 (51KA)
AVITA MEDICAL DL-0001 (F:51KA) has a market capitalization of $172.30 Million (€167.86 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #15921 globally and #1641 in its home market, demonstrating a -20.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AVITA MEDICAL DL-0001's stock price €6.35 by its total outstanding shares 26434700 (26.43 Million).
AVITA MEDICAL DL-0001 Market Cap History: 2020 to 2025
AVITA MEDICAL DL-0001's market capitalization history from 2020 to 2025. Data shows change from $415.16 Million to $172.30 Million (-30.90% CAGR).
AVITA MEDICAL DL-0001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AVITA MEDICAL DL-0001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 51KA by Market Capitalization
Companies near AVITA MEDICAL DL-0001 in the global market cap rankings as of March 19, 2026.
Key companies related to AVITA MEDICAL DL-0001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
AVITA MEDICAL DL-0001 Historical Marketcap From 2020 to 2025
Between 2020 and today, AVITA MEDICAL DL-0001's market cap moved from $415.16 Million to $ 172.30 Million, with a yearly change of -30.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €172.30 Million | -48.79% |
| 2024 | €336.47 Million | -2.36% |
| 2023 | €344.61 Million | +108.20% |
| 2022 | €165.52 Million | -41.90% |
| 2021 | €284.91 Million | -31.37% |
| 2020 | €415.16 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of AVITA MEDICAL DL-0001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $172.30 Million USD |
| MoneyControl | $172.30 Million USD |
| MarketWatch | $172.30 Million USD |
| marketcap.company | $172.30 Million USD |
| Reuters | $172.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.